These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12350196)

  • 1. Pharmacist care and clinical outcomes for patients with reactive airways disease.
    Strom BL; Hennessy S
    JAMA; 2002 Oct; 288(13):1642-3. PubMed ID: 12350196
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of pharmaceutical care program disappoint researchers.
    Young D
    Am J Health Syst Pharm; 2002 Nov; 59(22):2146, 2148. PubMed ID: 12455297
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial.
    Weinberger M; Murray MD; Marrero DG; Brewer N; Lykens M; Harris LE; Seshadri R; Caffrey H; Roesner JF; Smith F; Newell AJ; Collins JC; McDonald CJ; Tierney WM
    JAMA; 2002 Oct; 288(13):1594-602. PubMed ID: 12350190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient treatment of chronic obstructive pulmonary disease: comparisons with asthma.
    Sutherland ER
    J Allergy Clin Immunol; 2004 Oct; 114(4):715-24; quiz 725. PubMed ID: 15480305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of COPD, asthma, and ten comorbid conditions to health care utilization and patient-centered outcomes among US adults with obstructive airway disease.
    Murphy TE; McAvay GJ; Allore HG; Stamm JA; Simonelli PF
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2515-2522. PubMed ID: 28883718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a structured pharmacist-led inhalation technique assessment service for patients with asthma and COPD in Norwegian pharmacies.
    Ruud KW; Rønningen SW; Faksvåg PK; Ariansen H; Hovland R
    Patient Educ Couns; 2018 Oct; 101(10):1828-1837. PubMed ID: 29805072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory medicine team of the year.
    O'Dowd A
    BMJ; 2014 May; 348():g2941. PubMed ID: 24789473
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of helium-oxygen mixture in adult patients presenting with exacerbations of asthma and chronic obstructive pulmonary disease: a systematic review.
    Colebourn CL; Barber V; Young JD
    Anaesthesia; 2007 Jan; 62(1):34-42. PubMed ID: 17156225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can computer-generated evidence-based care suggestions enhance evidence-based management of asthma and chronic obstructive pulmonary disease? A randomized, controlled trial.
    Tierney WM; Overhage JM; Murray MD; Harris LE; Zhou XH; Eckert GJ; Smith FE; Nienaber N; McDonald CJ; Wolinsky FD
    Health Serv Res; 2005 Apr; 40(2):477-97. PubMed ID: 15762903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of asthmatic patients at four Western Cape community pharmacies.
    Bheekie A; Syce JA; Weinberg EG
    S Afr Med J; 1998 Mar; 88(3):262-6. PubMed ID: 9608292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist care for reactive airway disease.
    Guidry RT
    JAMA; 2003 Mar; 289(9):1103-4; author reply 1105-6. PubMed ID: 12622578
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacist care for reactive airway disease.
    Schulz M
    JAMA; 2003 Mar; 289(9):1104; author reply 1105-6. PubMed ID: 12622576
    [No Abstract]   [Full Text] [Related]  

  • 13. Differentiating the treatment of asthma and chronic obstructive pulmonary disease in the elderly patient.
    Davis E; Coover K; Morrow L; Malesker M
    Consult Pharm; 2012 Sep; 27(9):650-9. PubMed ID: 22982749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differences and similarities in the evaluation and diagnostic workup].
    Clarenbach CF; Kohler M
    Ther Umsch; 2014 May; 71(5):262-6. PubMed ID: 24794335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peak expiratory flow rate control chart in asthma care: chart construction and use in asthma care.
    Boggs PB; Wheeler D; Washburne WF; Hayati F
    Ann Allergy Asthma Immunol; 1998 Dec; 81(6):552-62. PubMed ID: 9892027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The UK Experience of COPD National Audit.
    Roberts CM
    Pneumonol Alergol Pol; 2012; 80(6):498-500. PubMed ID: 23109199
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ambulatory criteria of dry powder inhaler selection based on peak inspiratory flow recordings].
    Droszcz W; Droscez P
    Pneumonol Alergol Pol; 2002; 70(9-10):490-5. PubMed ID: 12710102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Salbutamol in Mixed Obstructive and Restrictive Pattern Spirometry.
    Tuladhar LR; Tamrakar Tuladhar ET
    Kathmandu Univ Med J (KUMJ); 2017 Oct.-Dec.; 15(60):279-283. PubMed ID: 30580341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in the assessment and management of airways diseases.
    Taylor DR; Pavord ID
    Postgrad Med J; 2008 Dec; 84(998):628-34; quiz 633. PubMed ID: 19201936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peak flow-based compared to symptom-based written action plans.
    National Education and Prevention and Prevention Program
    J Allergy Clin Immunol; 2002 Nov; 110(5 Suppl):S192-6. PubMed ID: 12518561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.